Stay updated on Belzutifan + Cabozantinib in ccRCC Clinical Trial

Sign up to get notified when there's something new on the Belzutifan + Cabozantinib in ccRCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belzutifan + Cabozantinib in ccRCC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The record describes a Phase 2 study of belzutifan plus cabozantinib for advanced clear cell renal cell carcinoma, including its eligibility criteria, treatment cohorts, study locations, and outcome measures. It also provides sponsor details, study dates, and related publications.
    Difference
    58%
    Check dated 2026-11-09T13:56:37.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T15:53:57.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A sitewide banner announces NIH website updates and a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T15:50:00.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov 403 error page.
    Difference
    0.2%
    Check dated 2026-10-19T15:55:42.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T16:08:07.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Access to the NCT03634540 study record is blocked by a 403 Forbidden error, replacing the expected study details with a generic error page.
    Difference
    19%
    Check dated 2026-09-21T22:22:17.000Z thumbnail image

Stay in the know with updates to Belzutifan + Cabozantinib in ccRCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belzutifan + Cabozantinib in ccRCC Clinical Trial page.